FdaApplication
ANDA 213932
Identifiers
- fda_app_no: ANDA213932
Properties
| Property | Value |
|---|---|
| applicant_name | SUN PHARMACEUTICAL INDUSTRIES LTD |
| application_type | ANDA |
| approval_date | 2022-09-30 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARIPRAZINE HYDROCHLORIDE | CARIPRAZINE HYDROCHLORIDE | EQ 6MG BASE | CAPSULE;ORAL |
| CARIPRAZINE HYDROCHLORIDE | CARIPRAZINE HYDROCHLORIDE | EQ 4.5MG BASE | CAPSULE;ORAL |
| CARIPRAZINE HYDROCHLORIDE | CARIPRAZINE HYDROCHLORIDE | EQ 3MG BASE | CAPSULE;ORAL |
| CARIPRAZINE HYDROCHLORIDE | CARIPRAZINE HYDROCHLORIDE | EQ 1.5MG BASE | CAPSULE;ORAL |
4 products